Why the study?
Vagus nerve stimulation can ameliorate acute pancreatitis, but it remains unknown whether these anti-inflammatory signals originate in the brain.
Does optogenetic stimulation of the brainstem dorsal motor nucleus reduce the severity of acute pancreatitis in a mouse model?
Does optogenetic stimulation of the brainstem dorsal motor nucleus reduce the severity of acute pancreatitis in a mouse model?
Selective optogenetic activation of brainstem DMN cholinergic neurons ameliorates acute pancreatitis via a vagus nerve and nicotinic acetylcholine receptor-dependent mechanism.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for DMN cholinergic neuromodulation in pancreatitis; leaves open translation to human therapy.
Introduction: Inflammation is an inherently self-amplifying process, resulting in progressive tissue damage when unresolved. A brake on this positive feedback system is provided by the nervous system which has evolved to detect inflammatory signals and respond by activating anti-inflammatory processes, including the cholinergic anti-inflammatory pathway mediated by the vagus nerve. Acute pancreatitis, a common and serious condition without effective therapy, develops when acinar cell injury activates intrapancreatic inflammation. Prior study has shown that electrical stimulation of the carotid sheath, which contains the vagus nerve, boosts the endogenous anti-inflammatory response and ameliorates acute pancreatitis, but it remains unknown whether these anti-inflammatory signals originate in the brain. Methods: Here, we used optogenetics to selectively activate efferent vagus nerve fibers originating in the brainstem dorsal motor nucleus of the vagus (DMN) and evaluated the effects on caerulein-induced pancreatitis. Results: Stimulation of the cholinergic neurons in the DMN significantly attenuates the severity of pancreatitis as indicated by reduced serum amylase, pancreatic cytokines, tissue damage, and edema. Either vagotomy or silencing cholinergic nicotinic receptor signaling by pre-administration of the antagonist mecamylamine abolishes the beneficial effects. Discussion: These results provide the first evidence that efferent vagus cholinergic neurons residing in the brainstem DMN can inhibit pancreatic inflammation and implicate the cholinergic anti-inflammatory pathway as a potential therapeutic target for acute pancreatitis.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: